No Data
No Data
Express News | Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of Ad04 as a Precision Medicine for the Treatment of Alcohol Use Disorder
EXCLUSIVE: Adial Pharmaceuticals Announces Publication In Journal Supporting the Potential Efficacy Of AD04 For Alcohol Use Disorder
On Thursday, Adial Pharmaceuticals Inc (NASDAQ:ADIL) announced the publication of previously disclosed results from its Phase 3 ONWARD study in a peer-reviewed article in the European Journal of Inter
Express News | Adial Pharmaceuticals Shares Are Trading Higher After the Company Announced That the First Patient Has Been Does in Its Pharmacokinetics Study of AD04 for Alcohol Use Disorder
Express News | Adial Pharmaceuticals Inc - Topline Results Expected in Early Q4 2024
Express News | Adial Pharmaceuticals- Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of Ad04 for Treatment of Alcohol Use Disorder
Express News | Adial Pharmaceuticals Doses First Patient In Pharmacokinetics Study Of AD04 For Treatment Of Alcohol Use Disorder
No Data